KLK3 and prostate carcinoma: The median time-to-CRPC, time from diagnosis of prostate cancer to CRPC, was 16.0 (IQR: 10.0–39.0) months, and the median PSA value at baseline before ENZ administration was 9.6 (IQR: 4.1–36.6) ng/mL.